Live Attenuated Viral Vaccine Development
Description
The development of a Live Attenuated Viral Vaccine involves isolating the virus, weakening it through passage or genetic modification, and testing it in animal models for safety and efficacy. The virus is then grown in cell cultures or eggs, purified, and formulated. Rigorous quality control ensures sterility, potency, and stability. After successful human trials, the vaccine is approved for public use.
Acknowledgements
References
Nunnally, B. K., Turula, V. E., & Sitrin, R. D. (2015). Vaccine analysis: Strategies, principles, and control. In Vaccine Analysis: Strategies, Principles, and Control. Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-45024-6
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
.gif)
